Keiretsu Forum Announces Dr. Martin Gershon as Keynote Speaker for 2024 Investor Capital Expo
02 oct. 2024 07h08 HE
|
Keiretsu Forum Mid-Atlantic
This signature event in early-stage investment community will be held on October 31, 2024, at Convene City View in Philadelphia.
Mabylon AG Receives Research Grants Totaling More Than CHF 1.3 Million for Amyotrophic Lateral Sclerosis (ALS) and Inflammasome Programs
24 sept. 2024 04h00 HE
|
AKAMPION
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has...
Yamaha Outdoor Access Initiative Awards Over $170,000 in Second Quarter Grants to Rebuild OHV Trails Affected by Natural Disasters
19 sept. 2024 15h00 HE
|
Yamaha Motor Corp., USA
MARIETTA, Ga., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA, awarded more than $170,000 in grants through its Yamaha Outdoor Access Initiative (OAI) in the second quarter of 2024,...
LiquidStack Secures $20 Million from Tiger Global to Bring Liquid Cooling to AI Data Centers on a Global Scale
19 sept. 2024 09h00 HE
|
LiquidStack
CARROLLTON, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) -- LiquidStack, a global leader in liquid cooling for data centers, today announced that it has secured a $20 million Series B extension investment...
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
19 sept. 2024 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds
18 sept. 2024 08h30 HE
|
Vaccinex, Inc.
ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to...
ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base
17 sept. 2024 04h00 HE
|
AKAMPION
Existing investors and new investor Double Point Ventures join forces to support ImmunOs TherapeuticsInvestment secures funding of ongoing promising clinical trial of IOS-1002 in solid cancers ...
REE Automotive Announces Global Manufacturing Agreement with Leading Automotive Supplier Motherson Group Making Strategic Investment in a $45.35 Million Registered Direct Offering Led By M&G
16 sept. 2024 08h31 HE
|
REE Automotive Ltd.
With this agreement, REE believes its ability to service customers at scale will materially accelerate.
Unlocking Business Growth at Takeoff University
11 sept. 2024 10h29 HE
|
Takeoff University
Marlton, New Jersey, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The entrepreneurial landscape thrives on innovation, but it also thrives on capital. For early-stage businesses, the dream of scaling can...
SOLASTA Bio Completes $14m Series A to Accelerate Nature-Inspired Crop Protection
11 sept. 2024 04h51 HE
|
SOLASTA Bio Ltd.
SOLASTA Bio, a leading agri-biotech company specialising in the next generation of green insecticides, has completed an oversubscribed $14 million Series A